Amgen : Update on Patent Litigation Related to Sandoz Denosumab Biosimilar Products
Amgen Update on Patent Litigation Related to Sandoz Denosumab Biosimilar Products We are pleased to have reached resolution of our patent infringement litigation related to...
United States Sandoz Denosumab Biosimilar Amgen Update Patent Litigation Related Sandoz Denosumab Biosimilar Products
Source: marketscreener.com